We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Implication of species change of Nontuberculous Mycobacteria during or after treatment.
- Authors
Jong Sik Lee; Jong Hyuk Lee; Soon Ho Yoon; Taek Soo Kim; Moon-Woo Seong; Sung Koo Han; Jae-Joon Yim; Lee, Jong Sik; Lee, Jong Hyuk; Yoon, Soon Ho; Kim, Taek Soo; Seong, Moon-Woo; Han, Sung Koo; Yim, Jae-Joon
- Abstract
<bold>Background: </bold>Co-existence or subsequent isolation of multiple nontuberculous mycobacteria (NTM) species in same patient has been reported. However, clinical significance of these observations is unclear. The aim of this study was to determine clinical implications of changes of NTM species during or after treatment in patients with NTM lung disease.<bold>Methods: </bold>Patients with NTM lung disease, who experienced changes of NTM species during treatment or within 2 years of treatment completion between January 1, 2009 and December 31, 2015, were included in the analysis. Demographic, clinical, microbiological, and radiographic data were reviewed and analyzed.<bold>Results: </bold>During the study period, 473 patients were newly diagnosed with NTM lung disease. Treatment was started in 164 patients (34.6%). Among these 164 patients, 16 experienced changes of NTM species during or within 2 years of treatment completion. Seven showed changes from M. avium complex (MAC) to M. abscessus subspecies abscessus (MAA) and five patients displayed changes from M. abscessus subspecies massiliense (MAM) to MAC. With isolation of new NTM species, 6 out of 7 patients with change from MAC to MAA reported worsening of symptoms, whereas none of the five patients with change from MAM to MAC reported worsening of symptoms. All MAA isolated during or after treatment for MAC lung diseases showed inducible resistance to clarithromycin.<bold>Conclusions: </bold>Change of NTM species may occur during or after treatment for NTM lung disease. Especially, changes from MAC to MAA is accompanied by symptomatic and radiographic worsening as well as inducible resistance to clarithromycin.
- Subjects
BIOLOGICAL classification; PERACETIC acid; MYCOBACTERIA; LUNG diseases; ALPHA 1-antitrypsin deficiency
- Publication
BMC Pulmonary Medicine, 2017, Vol 17, p1
- ISSN
1471-2466
- Publication type
journal article
- DOI
10.1186/s12890-017-0539-7